Précis: Increasing evidence points to a critical role for dyregulated patterns of alternate splicing in driving tumorigenesis, here illustrated by implications of a failure of differentiation pathways in a little understood but deadly childhood tumor. Précis: This study offers the first description of therapeutic activity for anti-IL-23 antibody in preclinical mouse models of cancer. Précis: A protein kinase C isoform implicated in apoptosis has a differential effect on cancer cell growth depending on the involvement of oncogenic KRAS in proliferation and survival, with potential implications on how to improve therapeutic targeting of mutant KRAS-driven tumors.
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